Affiliation:
1. Department of Conservative Dentistry and Endodontics, Poznan University of Medical Sciences, 60-812 Poznan, Poland
2. Student’s Scientific Group in Department of Conservative Dentistry and Endodontics, Poznan University of Medical Sciences, 60-812 Poznan, Poland
Abstract
Alzheimer’s Disease (AD) is the most common neurodegenerative disease which manifests with progressive cognitive impairment, leading to dementia. Considering the noninvasive collection of saliva, we designed the systematic review to answer the question “Are salivary biomarkers reliable for the diagnosis of Alzheimer’s Disease?” Following the inclusion and exclusion criteria, 30 studies were included in this systematic review (according to the PRISMA statement guidelines). Potential biomarkers include mainly proteins, metabolites and even miRNAs. Based on meta-analysis, in AD patients, salivary levels of beta-amyloid42 and p-tau levels were significantly increased, and t-tau and lactoferrin were decreased at borderline statistical significance. However, according to pooled AUC, lactoferrin and beta-amyloid42 showed a significant predictive value for salivary-based AD diagnosis. In conclusion, potential markers such as beta-amyloid42, tau and lactoferrin can be detected in the saliva of AD patients, which could reliably support the early diagnosis of this neurodegenerative disease.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference95 articles.
1. Molecular and Cellular Mechanisms Underlying the Pathogenesis of Alzheimer’s Disease;Guo;Mol. Neurodegener.,2020
2. The Epidemiology of Alzheimer’s Disease Modifiable Risk Factors and Prevention;Zhang;J. Prev. Alzheimers Dis.,2021
3. Diagnosis of Early Alzheimer’s Disease: Clinical Practice in 2021;Porsteinsson;J. Prev. Alzheimers Dis.,2021
4. Alzheimer’s Disease;Lane;Eur. J. Neurol.,2018
5. New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer’s Disease;Farias;J. Alzheimers Dis.,2021